Position in FHTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$127,382
-$159,896 QoQ
Shares Held
26,103
-56.6% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#51
of 102 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in FHTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BANK OF AMERICA CORP /DE/ holds $10,050,306,032 across 338 Biotechnology names. FHTX ranks #300 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,039,178 | $1,509,650,884 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,291,053 | $805,023,185 | |
| 3 | CYTK |
Cytokinetics Inc
|
4,635,709 | $394,916,048 | |
| 4 | ARGX |
Argenx SE
|
400,234 | $371,325,094 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
994,476 | $299,367,107 | |
| 6 | JAZZ |
Jazz Pharmaceuticals plc
|
1,136,091 | $273,763,844 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
4,568,341 | $259,527,450 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,149,422 | $232,658,090 |
All Filings in FHTX
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $127,382 | 26,103 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $287,278 | 60,100 | Shares | Defined | 2026-05-18 | |
| 2025-12-31 | $398,837 | 73,859 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $147,006 | 30,063 | Shares | Defined | 2026-02-03 | |
| 2025-06-30 | $147,095 | 31,297 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $86,996 | 23,835 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $149,443 | 31,662 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $257,513 | 27,660 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $154,714 | 26,907 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $85,403 | 12,728 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $187,520 | 29,073 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $68,490 | 13,698 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $52,961 | 7,523 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $52,141 | 8,410 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $90,525 | 14,189 | Shares | Defined | 2023-02-10 | |
| 2022-09-30 | $77,846 | 9,073 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $152,809 | 11,236 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $228,876 | 15,028 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $457,696 | 20,013 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $166,881 | 11,980 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $130,920 | 12,270 | Shares | Defined | 2021-09-13 | |
| 2021-03-31 | $71,290 | 5,409 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $33,526 | 1,654 | Shares | Defined | 2021-02-10 | |
| No filing history on record for this holder in this stock. | ||||||